Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2023 | How to manage active surveillance in 2023: minimal requirements for histopathology of biopsies

Eva Compérat • 7 Mar 2023
EAU 2023
Genitourinary Cancer Prostate Cancer

Eva Compérat, MD, PhD, Medical University of Vienna, Vienna, Austria, discusses the minimal requirements for histopathology of biopsies for prostate cancer in regard to managing active surveillance in 2023. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Eva Compérat

5:03
Challenges in classifying bladder tumors: insights on heterogeneity and precision
Eva Compérat • 21 Nov 2023
2:41
Unraveling grading challenges in bladder tumors
Eva Compérat • 21 Nov 2023
2:58
Challenges in staging urinary tract tumors
Eva Compérat • 21 Nov 2023
1:59
Subtypes of prostate cancer and how they change our management
Eva Compérat • 7 Mar 2023

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals